Larn Hwang
Impact in
-
- Nanoparticle-Based Drug Delivery
-
- Pancreatic and Hepatic Oncology Research
- Cancer Treatment and Pharmacology
- Cancer Cells and Metastasis
Papers in
- Oncology 9
- Cancer Treatment and Pharmacology 4
- Cancer Cells and Metastasis 4
- HER2/EGFR in Cancer Research 2
-
- TGF-β signaling in diseases 4
- Cancer-related gene regulation 2
- Co-authors
- Vuong Trieu (17 shared papers)Neil Desai (1 shared paper)William J. Gradishar (1 shared paper)Patrick Soon‐Shiong (1 shared paper)Richard Baer (2 shared papers)Laurie S. Davis (1 shared paper)Nancy Oppenheimer‐Marks (1 shared paper)Mark Siegelman (1 shared paper)
- Journals
- Journal of Clinical Oncology (6 papers)Cancer Research (5 papers)The American Journal of Gastroenterology (1 paper)Cancers (1 paper)Anti-Cancer Drugs (1 paper)
- Partner nations
- United States
In The Last Decade
Larn Hwang
18 papers receiving 328 citations
Peers
Comparison fields: 5 of 53
- Biomaterials 67
- Oncology 112
- Cancer Research 47
- Genetics 24
- Pharmaceutical Science 15
Countries citing papers authored by Larn Hwang
This map shows the geographic impact of Larn Hwang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Larn Hwang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Larn Hwang more than expected).
Fields of papers citing papers by Larn Hwang
This network shows the impact of papers produced by Larn Hwang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Larn Hwang. The network helps show where Larn Hwang may publish in the future.
Co-authors
The 25 scholars most cited alongside Larn Hwang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 172 | |
| 2 | Expression of the TAL1 proto-oncogene in cultured endothelial cells and blood vessels of the spleen. | 1993 | 57 |
| 3 | 2019 | 32 | |
| 4 | Products of the TAL2 oncogene in leukemic T cells: bHLH phosphoproteins with DNA-binding activity. | 1994 | 26 |
| 5 | 2018 | 23 | |
| 6 | 2016 | 8 | |
| 7 | 2017 | 5 | |
| 8 | 2017 | 3 | |
| 9 | 2016 | 3 | |
| 10 | 2017 | 2 | |
| 11 | 2017 | 2 | |
| 12 | In silico Molecular Target Validation Demonstrates Transforming Growth Factor Beta 2 is Strongly Expressed in Pediatric Diffuse Intrinsic Pontine Glioma and Glioblastoma Multiforme | 2019 | 2 |
| 13 | 2020 | 1 | |
| 14 | 2010 | 1 | |
| 15 | 2013 | 1 | |
| 16 | 2013 | 1 | |
| 17 | 2017 | 1 | |
| 18 | 2010 | 1 | |
| 19 | 2013 | 1 | |
| 20 | 2019 | 0 |
About Larn Hwang
Larn Hwang is a scholar working on Oncology, Molecular Biology, Cancer Research, Biotechnology and Genetics, having authored 20 papers that have together received 342 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (4 papers), Cancer Cells and Metastasis (4 papers), TGF-β signaling in diseases (4 papers), Cancer Research and Treatments (4 papers), Cancer, Hypoxia, and Metabolism (4 papers), Nanoparticle-Based Drug Delivery (2 papers), Cancer-related gene regulation (2 papers) and HER2/EGFR in Cancer Research (2 papers). The work is most often cited by research in Biomaterials (67 citations), Oncology (112 citations), Cancer Research (47 citations), Genetics (24 citations) and Pharmaceutical Science (15 citations). Larn Hwang has collaborated with scholars based in United States. Frequent co-authors include Vuong Trieu, Neil Desai, William J. Gradishar, Patrick Soon‐Shiong, Richard Baer, Laurie S. Davis, Nancy Oppenheimer‐Marks, Mark Siegelman, Fatih M. Uckun and Sanjive Qazi. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, The American Journal of Gastroenterology, Cancers and Anti-Cancer Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.